The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate cancer screening, says ...
Apr 9, 2024
0
4
As part of a comprehensive effort to improve cancer screenings among diverse communities, Penn Medicine's Abramson Cancer Center (ACC) Community Outreach and Engagement team developed a culturally sensitive educational video ...
Apr 9, 2024
0
0
Removing one step from a three-part MRI scan, which could make them quicker, cheaper, and more accessible, had no negative impact on diagnostic accuracy, according to clinical trial results led by UCL and UCLH.
Apr 8, 2024
0
0
Microvascular function is lower is Black men following a recent diagnosis of prostate cancer, compared to white men, according to researchers at the Medical College of Georgia. Researchers presented their work at the American ...
Apr 8, 2024
0
0
SYNC-T, an investigational therapy that combines a device-induced vaccination at the tumor site with intratumoral infusion of a multitarget biologic drug led to numerous clinical responses in patients with metastatic castrate-resistant ...
Apr 8, 2024
0
0
Integrating magnetic resonance imaging (MRI) into prostate cancer (PCa) screening is associated with a reduction in unnecessary biopsies and overdiagnosis of insignificant disease, according to a review published online April ...
Apr 8, 2024
0
1
The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of ...
Apr 6, 2024
0
122
A simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.
Apr 5, 2024
0
0
Annual prostate cancer cases worldwide are projected to double by the year 2040, and annual deaths are projected to increase by 85% to almost 700,000 over the same timeframe—mainly among men in low- and middle-income countries. ...
Apr 4, 2024
1
106
Patients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a study published online March 19 in the Journal of the American Academy of Dermatology.
Apr 4, 2024
0
0
